BeiGene Ltd. (BGNE)
NASDAQ: BGNE
· Real-Time Price · USD
184.71
0.90 (0.49%)
At close: Dec 31, 2024, 10:00 PM
BeiGene Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product Revenue | 1.66B | 1.11B | 746.92M | 630.53M | 595.29M | 553.75M | 410.29M | 339.02M | 349.51M | 304.51M | 261.57M | 251M | 206.03M | 148.31M | 143.48M | 108.46M | 95.33M | 67.69M | 53.19M | 59.03M | 52.46M | 58.73M | 58.54M | 20.91M | 15.76M | 21.38M | 9.29M |
Product Revenue Growth | +49.55% | +48.41% | +18.46% | +5.92% | +7.50% | +34.96% | +21.02% | -3.00% | +14.78% | +16.42% | +4.21% | +21.83% | +38.92% | +3.37% | +32.29% | +13.77% | +40.84% | +27.26% | -9.90% | +12.52% | -10.68% | +0.34% | +179.97% | +32.71% | -26.30% | +130.02% | n/a |
Collaboration Revenue | 13.22M | 8.75M | 4.73M | 3.88M | 186.02M | 41.52M | 37.51M | 41.07M | 38.12M | 37.06M | 45.05M | 17.19M | 13.98M | 11.37M | 499.75M | n/a | n/a | n/a | n/a | n/a | n/a | 185.2M | 20.41M | n/a | n/a | n/a | n/a |
Collaboration Revenue Growth | +51.15% | +84.81% | +21.92% | -97.91% | +348.06% | +10.68% | -8.67% | +7.74% | +2.86% | -17.74% | +162.03% | +23.00% | +22.97% | -97.73% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +807.33% | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All Other Countries Except China And United States Of America Revenue | 35.56M | 31.92M | 12.96M | n/a | 287.94M | 36.29M | 35.87M | 22.41M | 19.57M | 14.82M | 16.47M | 6.21M | 4.19M | 3.51M | 149.93M | 91.34M | 85.38M | 62.58M | 51.34M | 1K | 50.14M | 64.82M | 7.14M | 7.32M | 5.51M | 6.96M | 3.25M |
All Other Countries Except China And United States Of America Revenue Growth | +11.41% | +146.31% | n/a | -100.00% | +693.52% | +1.17% | +60.03% | +14.56% | +32.03% | -10.00% | +165.02% | +48.14% | +19.45% | -97.66% | +64.13% | +6.98% | +36.45% | +21.88% | +5134100.00% | -100.00% | -22.65% | +807.35% | -2.38% | +32.72% | -20.74% | +113.86% | n/a |
China Revenue | 432.92M | 399.59M | 320.38M | 273.19M | 85.58M | 293.92M | 246.91M | 203.59M | 233.27M | 212.43M | 190.74M | 139.78M | 158.78M | 122.64M | 95.98M | 8.76M | 5.7M | 3.06M | 717K | 55.85M | n/a | 58.14M | 57.42M | 93.94M | 38.45M | n/a | n/a |
China Revenue Growth | +8.34% | +24.73% | +17.27% | +219.21% | -70.88% | +19.04% | +21.27% | -12.72% | +9.81% | +11.37% | +36.45% | -11.96% | +29.47% | +27.77% | +996.19% | +53.72% | +86.20% | +326.64% | -98.72% | n/a | n/a | +1.26% | -38.87% | +144.33% | n/a | n/a | n/a |
Europe Revenue | 152.38M | 118.55M | 66.86M | 116.43M | 398.23M | 223.54M | 165.03M | 154.09M | 134.79M | 114.32M | 99.42M | 67.98M | 43.47M | 23.85M | 359.96M | n/a | n/a | n/a | n/a | 1.04M | n/a | 120.38M | 13.27M | 32.55M | 10.24M | n/a | n/a |
Europe Revenue Growth | +28.54% | +77.32% | -42.58% | -70.76% | +78.15% | +35.46% | +7.10% | +14.32% | +17.90% | +14.99% | +46.25% | +56.39% | +82.30% | -93.38% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +807.32% | -59.24% | +217.86% | n/a | n/a | n/a |
United States Revenue | 694.43M | 567.21M | 351.46M | 341.43M | 9.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
United States Revenue Growth | +22.43% | +61.39% | +2.94% | +3471.02% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 537.91M | 459.29M | 504.68M | 455.22M | 443.73M | 427.43M | 416.55M | 364.42M | 395.03M | 328.5M | 328.98M | 322.89M | 331.4M | 294.57M | 306.5M | 269.23M | 232.29M | 182.11M | 208.21M | 160.84M | 124.05M | 107.08M | 143.35M | 105M | 82.25M | 57.65M | 72.49M | 48.82M | 45.16M | 28.91M | 27.41M | 15.64M | 10.78M | 8.77M | 8.34M | 4.72M | 3.9M | 3.13M | 2.95M | 2.02M | 1.21M | 1.13M |
Selling, General, and Administrative Revenue Growth | +17.12% | -8.99% | +10.86% | +2.59% | +3.81% | +2.61% | +14.30% | -7.75% | +20.25% | -0.15% | +1.89% | -2.57% | +12.50% | -3.89% | +13.84% | +15.90% | +27.56% | -12.54% | +29.45% | +29.66% | +15.85% | -25.30% | +36.53% | +27.67% | +42.68% | -20.48% | +48.48% | +8.10% | +56.18% | +5.47% | +75.28% | +45.13% | +22.90% | +5.18% | +76.56% | +20.95% | +24.57% | +6.24% | +45.97% | +67.30% | +6.71% | n/a |
Research and Development Revenue | 524.9M | 481.89M | 542.01M | 496.18M | 454.47M | 460.64M | 493.99M | 453.26M | 422.76M | 408.58M | 446.02M | 426.36M | 378.21M | 389.92M | 430.49M | 351.94M | 356.09M | 320.73M | 355.54M | 349.07M | 285.97M | 304.3M | 283.26M | 236.97M | 228.76M | 178.35M | 257.46M | 147.59M | 164.25M | 109.7M | 91.34M | 87.66M | 47.24M | 42.77M | 28.93M | 30.11M | 21.12M | 17.88M | 28.1M | 13.35M | 6.74M | 10.06M |
Research and Development Revenue Growth | +8.93% | -11.09% | +9.24% | +9.18% | -1.34% | -6.75% | +8.99% | +7.21% | +3.47% | -8.39% | +4.61% | +12.73% | -3.00% | -9.42% | +22.32% | -1.17% | +11.03% | -9.79% | +1.85% | +22.07% | -6.02% | +7.43% | +19.53% | +3.59% | +28.26% | -30.73% | +74.45% | -10.14% | +49.73% | +20.10% | +4.20% | +85.54% | +10.46% | +47.83% | -3.90% | +42.57% | +18.12% | -36.39% | +110.49% | +98.17% | -33.03% | n/a |